GLP-1 and Glucagon Secretion from a Pancreatic Neuroendocrine Tumor Causing Diabetes and Hyperinsulinemic Hypoglycemia | Zendy

Rachel Roberts | Zendy; Min Zhao | Zendy; Ben Whitelaw | Zendy; John Ramage | Zendy; Salvador J. DíazCano | Zendy; Carel W. le Roux | Zendy; Alberto Quaglia | Zendy; Guo Huang | Zendy; Simon Aylwin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

GLP-1 and Glucagon Secretion from a Pancreatic Neuroendocrine Tumor Causing Diabetes and Hyperinsulinemic Hypoglycemia

Author(s) -

Rachel Roberts,

Min Zhao,

Ben Whitelaw,

John Ramage,

Salvador J. DíazCano,

Carel W. le Roux,

Alberto Quaglia,

Guo Huang,

Simon Aylwin

Publication year - 2012

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2005

Subject(s) - hyperinsulinemic hypoglycemia , medicine , endocrinology , glucagon , hypoglycemia , insulin , pancreas , islet , biology

Glucagon-like peptide-1 (GLP-1) is a gut peptide that promotes insulin release from pancreatic β-cells and stimulates β-cell hyperplasia. GLP-1 secretion causing hypoglycemia has been described once from an ovarian neuroendocrine tumor (NET) but has not been reported from a pancreatic NET (pNET).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research